FARMACOM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FARMACOM
Largest movements
- Cash -€213,272
down €213,272 (-75.9%), from €280,870 to €67,598
mainly Current investments (-€200,000) and Other debts (-€42,394)
- Current investments +€200,000
new in 2024: €200,000
- Tangible fixed assets -€37,578
down €37,578 (-6.5%), from €580,231 to €542,654
of which Land and buildings: -€36,798
- Other debts -€42,394
down €42,394 (-23.5%), from €180,178 to €137,784
- Gross operating margin +€5,423
up €5,423 (+16.3%), from €33,366 to €38,789
- Other operating charges -€2,458
down €2,458 (-21.6%), from €11,406 to €8,948
- Depreciation -€1,520
down €1,520 (-3.8%), from €40,017 to €38,497
- Taxes -€678
new in 2024: -€678
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €868,445 | €818,096 | -€50,349 | -5.8% |
| Fixed assets | 21/28 | €580,231 | €542,654 | -€37,578 | -6.5% |
| Tangible fixed assets | 22/27 | €580,231 | €542,654 | -€37,578 | -6.5% |
| Land and buildings | 22 | €575,468 | €538,670 | -€36,798 | -6.4% |
| Plant, machinery and equipment | 23 | €4,763 | €3,984 | -€780 | -16.4% |
| Current assets | 29/58 | €288,213 | €275,442 | -€12,771 | -4.4% |
| Amounts receivable within one year | 40/41 | €7,343 | €7,844 | +€501 | +6.8% |
| Trade receivables | 40 | €2,280 | €1,716 | -€564 | -24.8% |
| Other amounts receivable | 41 | €5,063 | €6,128 | +€1,065 | +21.0% |
| Current investments | 50/53 | - | €200,000 | +€200,000 | |
| Cash at bank and in hand | 54/58 | €280,870 | €67,598 | -€213,272 | -75.9% |
| Total equity and liabilities | 10/49 | €868,445 | €818,096 | -€50,349 | -5.8% |
| Equity | 10/15 | €675,777 | €669,979 | -€5,797 | -0.9% |
| Contributions | 10/11 | €773,428 | €773,428 | = | 0.0% |
| Capital | 10 | €773,428 | €773,428 | = | 0.0% |
| Issued capital | 100 | €773,428 | €773,428 | = | 0.0% |
| Reserves | 13 | €434,023 | €427,835 | -€6,188 | -1.4% |
| Non-distributable reserves | 130/1 | €9,394 | €9,394 | = | 0.0% |
| Legal reserve | 130 | €9,394 | €9,394 | = | 0.0% |
| Tax-exempt reserves | 132 | €250,790 | €244,602 | -€6,188 | -2.5% |
| Distributable reserves | 133 | €173,839 | €173,839 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€531,674 | -€531,284 | +€390 | +0.1% |
| Provisions and deferred taxes | 16 | €11,813 | €8,626 | -€3,186 | -27.0% |
| Deferred taxes | 168 | €11,813 | €8,626 | -€3,186 | -27.0% |
| Amounts payable | 17/49 | €180,856 | €139,490 | -€41,366 | -22.9% |
| Amounts payable within one year | 42/48 | €180,856 | €139,490 | -€41,366 | -22.9% |
| Trade debts | 44 | - | €1,706 | +€1,706 | |
| Suppliers | 440/4 | - | €1,706 | +€1,706 | |
| Taxes, remuneration and social security | 45 | €678 | - | -€678 | |
| Taxes | 450/3 | €678 | - | -€678 | |
| Other amounts payable | 47/48 | €180,178 | €137,784 | -€42,394 | -23.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €40,017 | €38,497 | -€1,520 | -3.8% |
| Other operating charges | 640/8 | €11,406 | €8,948 | -€2,458 | -21.6% |
| Gross operating margin | 9900 | €33,366 | €38,789 | +€5,423 | +16.3% |
| Operating profit (loss) | 9901 | -€18,057 | -€8,656 | +€9,401 | +52.1% |
| Financial charges | 65/66B | €1,001 | €1,006 | +€5 | +0.4% |
| Recurring financial charges | 65 | €1,001 | €1,006 | +€5 | +0.4% |
| Profit (loss) for the period before taxes | 9903 | -€19,058 | -€9,661 | +€9,397 | +49.3% |
| Transfer from deferred taxes | 780 | €3,186 | €3,186 | = | 0.0% |
| Income taxes | 67/77 | - | -€678 | -€678 | |
| Profit (loss) for the period | 9904 | -€15,872 | -€5,797 | +€10,074 | +63.5% |
| Transfer from tax-exempt reserves | 789 | €6,188 | €6,188 | = | 0.0% |
| Profit (loss) for the period to be appropriated | 9905 | -€9,684 | €390 | +€10,074 |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.